I-BODY

What this means for you

Not registered yet, but its 04 Apr 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79368363

Mark type

Stylized text

Filed

04 Apr 2023

Attorney of record

Cheryl L. Burbach

Goods and services

• Class 005 — Pharmaceuticals: Pharmaceutical, biotechnology and medical preparations and substances for medical use or purposes, namely, pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, biological preparations for the treatment of fibrosis, cancer and other diseases; Pharmaceutical, biotechnology and medical preparations and substances for medical use or purposes, namely, prescription injectable pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, prescription injectable biological preparations for the treatment of fibrosis, cancer and other diseases, inhaled pharmaceutical preparations for the treatment of fibrosis, cancer and other diseases, inhaled biological preparations for the treatment of fibrosis, cancer and other diseases; diagnostic preparations and reagents for medical purposes; antibodies for medical purposes; antibody fragments for medical purposes; antibody fragments for combining with other chemicals, proteins and cells for medical or diagnostic purposes; antibody conjugates for medical purposes; immunological antibodies for medical use; monoclonal antibodies for medical diagnostic use; monoclonal antibodies for medical use; monoclonal antibodies for therapeutic purposes; preparations containing antibodies for use in medicine; proteins for medical use in binding antibodies; proteins for medical use in detecting antibodies; reagents for medical research use in the development of monoclonal antibodies for medical purposes; molecular targets for drug and vaccine development, all in the nature of biological reagents for medical research use; tagged antibodies for medical research and medical use; vaccines; vaccines against cancer viral or bacterial infection; vaccines for human use; vaccine adjuvants; diagnostic preparations, reagents, substances, products and testing materials for medical purposes, namely, for capturing, imaging, detecting, identifying or characterising protein and cell therapeutic candidates; reagents for use in diagnostic tests for medical purposes; reagents for medical research applications for medical diagnosis; biological tissue, namely, recombinant human protein production cell line for medical use or modified human cells for therapeutic use; biological tissue, namely recombinant human protein production cell line for modified human cells for therapeutic use; proteins for medical use in recombinant DNA technology; biological reagents for use in molecular biology for medical purposes

Owner

• AdAlta Limited, AU

Prosecution history

• 28 Oct 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 27 Oct 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 24 Apr 2025 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
• 20 Apr 2025 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
• 12 Oct 2024 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 25 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 25 Sept 2024 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 13 Sept 2024 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
• 13 Sept 2024 — LETTER OF SUSPENSION E-MAILED
• 13 Sept 2024 — SUSPENSION LETTER WRITTEN
• 22 Jul 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 22 Jul 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 22 Jul 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 19 Feb 2024 — REFUSAL PROCESSED BY IB
• 29 Jan 2024 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB